Immunomodulatory properties of a 1,25(OH)(2) vitamin D(3) analog combined with IFNbeta in an animal model of syngeneic islet transplantation.
van Etten
E
E
Laboratory of Experimental Medicine and Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium.
Gysemans
C
C
Verstuyf
A
A
Bouillon
R
R
Mathieu
C
C
D000480:Alkynes; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002762:Cholecalciferol / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods*; D016899:Interferon-beta / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D051379:Mice; D016688:Mice, Inbred NOD; D012008:Recurrence; D013237:Stereoisomerism; D013370:Subrenal Capsule Assay; D014185:Transplantation, Isogeneic / Q000276:immunology*
D000480:Alkynes; D001786:Blood Glucose; C409043:inecalcitol; D002762:Cholecalciferol; D016899:Interferon-beta; D016572:Cyclosporine